BRT Biotechnologies is aiming to drug the undruggable. Our proprietary platform allows for ultra-high-throughput synthesis of large and diverse small molecule libraries that can be directly screened for activity. Our synthetic approach uses no tags and no barcodes and our libraries are ready for your phenotypic or target-based drug discovery screen.